okredo logo
none title certification

UAB "CSO Pharma Baltic" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
311,406
31,423
10,169
9,775
986
0.20
0.34
30.84
3.14
67,789
23,356
418
92,419
2022
312,708
33,990
19,230
-19,130
-2,079
0.13
0.70
34.19
-6.12
48,659
33,912
12,083
70,397
2023
420,311
52,539
7,873
-7,868
-984
0.08
0.52
30.70
-1.87
40,791
21,120
8,175
55,752
unlock data icon

Register and

explore Okredo data
2023
420,311
52,539
7,873
-7,868
-984
0.08
0.52
30.70
-1.87
40,791
21,120
8,175
55,752
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

420,311 €Ascended34 % *

Sales per employee (€)

52,539 €Ascended55 % *

Profit before tax (€)

7,873 €Descended-59 % *

Net Profit (€)

-7,868 €Ascended59 % *

Profit per employee (€)

-984 €Ascended53 % *

Working capital requirement

0.08 Descended-38.46 % *

Debt-to-equity ratio

0.52 Descended-25.71 % *

Total profitability (%)

30.70 %Descended-10.21 % *

Net profitability (%)

-1.87 %Ascended69.44 % *

Equity (€)

40,791 €Descended-16 % *

Amounts Payable And Liabilities (€)

21,120 €Descended-38 % *

Non-current Assets (€)

8,175 €Descended-32 % *

CurrentAssets (€)

55,752 €Descended-21 % *

*over the last year starting selected period